Apigat 2.5 Tablet

By Apigat

Rx

30 Tablet in a Bottle

Composition icon

Composition

Apixaban(2.5mg)

Manufacturer - Natco Pharma Ltd icon

Manufacturer - Natco Pharma Ltd

Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Expires on or after icon

Expires on or after

January, 2027

About Apigat 2.5 Tablet

Apigat 2.5 Tablet is a medication categorized as an anticoagulant, commonly referred to as a blood thinner. This drug plays a vital role in preventing and treating blood clots that can form in various areas of the body, including the veins in the legs, lungs, brain, and heart. It is notably useful in reducing the risk of serious conditions such as stroke and heart attack.

Individuals with irregular heart rhythms, particularly atrial fibrillation, often use Apigat 2.5 Tablet to deter clot formation. Moreover, it is beneficial for those who have undergone elective surgeries, like knee or hip replacements, to prevent clotting. The medication is designed to be taken consistently, preferably at the same time each day, with or without food. In some cases, patients may need to continue taking Apigat 2.5 Tablet for long durations, potentially even for life under medical supervision.

It is crucial not to discontinue this medication or alter the dosage without consulting a medical professional, as doing so could elevate the risk of severe health complications such as heart attack, stroke, or thrombosis. Lifestyle modifications, including refraining from smoking, adopting a healthy diet, engaging in regular physical activity, and managing weight, can aid in decreasing the likelihood of developing blood clots while on this medication.

The most frequently reported side effect of Apigat 2.5 Tablet is increased susceptibility to bleeding, evidenced by symptoms like nosebleeds or easy bruising. Patients should promptly inform their healthcare provider if they experience any unexpected symptoms. Other potential side effects of this medication include hematoma, anemia, and nausea.

It is imperative to note that individuals with severe kidney or liver issues, current bleeding episodes, or taking other blood-thinning medications should avoid Apigat 2.5 Tablet. Additionally, breastfeeding while using this medication is not recommended. Unlike some anticoagulants, regular blood testing for clotting factors is not necessary during the course of treatment with Apigat 2.5 Tablet.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

720

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024